Navigation Links
Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
Date:1/23/2008

ARTISTE Solution Offers Unprecedented Flexibility for Tailoring Treatments

to Individual Patient Needs

CONCORD, Calif., Jan. 23 /PRNewswire/ -- Siemens Medical Solutions (http://www.usa.siemens.com/medical) announced it has received FDA 510(k) marketing clearance for the sale and distribution of its most recent innovation in radiation therapy technology, the ARTISTE(TM) Solution.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080123/NYW124 )

Developed by Siemens' Oncology Care Systems, the ARTISTE Solution is a linear accelerator engineered specifically for Adaptive Radiation Therapy (ART). Unique in design, ARTISTE is an integrated imaging and workflow solution that provides a comprehensive portfolio of image-guided and advanced treatment delivery protocols.

This new radiation therapy solution offers clinicians multiple imaging modalities. From Megavoltage (MV) to gold-standard, in-room CT imaging, clinicians can select the optimal imaging application for their treatment approach. Siemens' MVision(TM) Cone Beam Imaging Package delivers outstanding soft-tissue resolution, especially in challenging cases, such as imaging prostheses and with large patients. The CTVision(TM) CT-on-rails System provides in-room, diagnostic quality imaging; thus opening up opportunities to implement benchmark concepts, such as daily re-planning.

"Patient anatomy and tumor size and shape change during the course of treatment, often making it difficult to maximize dosage to target tissue while sparing healthy tissue," said Holger Schmidt, president of Siemens Medical Solutions, Oncology Care Systems Division. "ARTISTE provides both fast, powerful 3D MV imaging and CT high-contrast imaging to help monitor daily changes and enable precise radiation treatment delivery. Along with the improved tumor conformity, high-leaf speed, and low leakage of the new 160 MLC(TM) Multileaf Collimator, ARTISTE empowers clinicians -. offering them the flexibility and assurance they need to deliver optimal care."

ARTISTE's design incorporates an array of proven components that reinforces clinicians' confidence in adapting protocols for each patient. For precise patient positioning, the 550 TxT(TM) Treatment Table meets the growing demand for accuracy and stability, while providing the mechanical strength to accommodate a patient weight capacity of up to 550 lbs (250 kg). The ARTISTE Solution is further enhanced by Siemens' comprehensive software solution, syngo(R) Suite for Oncology, a workflow platform providing scalable workspaces that enable clinical team members to access data, patient information, and images as needed.

"Worldwide demographics continue to change and healthcare demands are on the rise. Higher cancer rates and the increasing need for radiation therapy solutions pose many questions, and Siemens has answers," said Schmidt. "With innovations like ARTISTE, we provide the reliability and options that support optimized radiation therapy and simplified clinical workflow, as well as a clear upgrade path for the incorporation of changes in clinical scope and future treatment advances."

Siemens is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens will be the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. The company delivers solutions across the entire continuum of care -- from prevention and early detection, to diagnosis, therapy and care. Siemens Healthcare employs more than 49,000 people worldwide and operates in 130 countries. According to IFRS, in the fiscal year 2007 (Sept. 30), Siemens Medical Solutions reported sales of euro 9.85 billion, orders of euro 10.27 billion, and group profit of euro 1.32 billion (preliminary figures, unaudited). Further information can be found by visiting http://www.siemens.com/medical.


'/>"/>
SOURCE Siemens Medical Solutions
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
6. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
7. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
10. Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007
11. James Cracknell Launches Siemens Stroke for Stroke Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... Calif. , April 19, 2017  SARES•REGIS ... buildings it is developing at Conejo Spectrum Business ... , to Atara Biotherapeutics, Inc. , a ... severe and life-threatening diseases that have been underserved ... allogeneic T-cell therapies for cancer, autoimmune and infectious ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: